These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 33913607)

  • 1. European legislation for veterinary medicines: Would a monograph system improve the environmental risk assessment?
    de la Casa-Resino I; Haro Castuera A; Casimiro Elena R; Rubio Montejano C; Carapeto García R
    Integr Environ Assess Manag; 2021 Nov; 17(6):1274-1285. PubMed ID: 33913607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-European traditional herbal medicines in Europe: a community herbal monograph perspective.
    Qu L; Zou W; Zhou Z; Zhang T; Greef J; Wang M
    J Ethnopharmacol; 2014 Oct; 156():107-14. PubMed ID: 25169214
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Environmental Risk Assessment of Nanomaterials in the Light of New Obligations Under the REACH Regulation: Which Challenges Remain and How to Approach Them?
    Schwirn K; Voelker D; Galert W; Quik J; Tietjen L
    Integr Environ Assess Manag; 2020 Sep; 16(5):706-717. PubMed ID: 32175661
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Environmental risk assessment of veterinary pharmaceuticals in the EU: reply to Montforts and de Knecht.
    Long C; Crane M
    Toxicol Lett; 2003 May; 142(3):219-25. PubMed ID: 12691715
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Three methods for integration of environmental risk into the benefit-risk assessment of veterinary medicinal products.
    Chapman JL; Porsch L; Vidaurre R; Backhaus T; Sinclair C; Jones G; Boxall ABA
    Sci Total Environ; 2017 Dec; 605-606():692-701. PubMed ID: 28675879
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Environmental Risk Assessment of Technical Mixtures Under the European Registration, Evaluation, Authorisation and Restriction of Chemicals-A Regulatory Perspective.
    Galert W; Hassold E
    Integr Environ Assess Manag; 2021 May; 17(3):498-506. PubMed ID: 33448633
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Environmental risk assessment of veterinary medicinal products in the EU--a regulatory perspective.
    Koschorreck J; Koch C; Rönnefahrt I
    Toxicol Lett; 2002 May; 131(1-2):117-24. PubMed ID: 11988364
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Practical advice for selecting or determining trophic magnification factors for application under the European Union Water Framework Directive.
    Kidd KA; Burkhard LP; Babut M; Borgå K; Muir DC; Perceval O; Ruedel H; Woodburn K; Embry MR
    Integr Environ Assess Manag; 2019 Mar; 15(2):266-277. PubMed ID: 30298984
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Strengthening and rationalizing pharmacovigilance in the EU: where is Europe heading to? A review of the new EU legislation on pharmacovigilance.
    Borg JJ; Aislaitner G; Pirozynski M; Mifsud S
    Drug Saf; 2011 Mar; 34(3):187-97. PubMed ID: 21332243
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Life Cycle Assessment support to environmental ambitions of EU policies and the Sustainable Development Goals.
    Sanyé-Mengual E; Sala S
    Integr Environ Assess Manag; 2022 Sep; 18(5):1221-1232. PubMed ID: 35112502
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Veterinary pharmacovigilance. Part 1. The legal basis in the European Union.
    Woodward KN
    J Vet Pharmacol Ther; 2005 Apr; 28(2):131-47. PubMed ID: 15842304
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The EU Green Deal's ambition for a toxic-free environment: Filling the gap for science-based policymaking.
    van Dijk J; Leopold A; Flerlage H; van Wezel A; Seiler TB; Enrici MH; Bloor MC
    Integr Environ Assess Manag; 2021 Nov; 17(6):1105-1113. PubMed ID: 33860613
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mobility in the context of exposure-based assessment of chemicals for drinking water resource protection.
    Pawlowski S; Aicher L; Berends A; Curtis-Jackson P; Häner A; Hollender J; Jene B; Jenner K; Redman A; Sanders G; Vallotton N; Wang N; Wheeler JR
    Integr Environ Assess Manag; 2023 May; 19(3):775-791. PubMed ID: 36281826
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The use of terrestrial and aquatic microcosms and mesocosms for the ecological risk assessment of veterinary medicinal products.
    Van den Brink PJ; Tarazona JV; Solomon KR; Knacker T; Van den Brink NW; Brock TC; Hoogland JP
    Environ Toxicol Chem; 2005 Apr; 24(4):820-9. PubMed ID: 15839555
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Toward the definition of specific protection goals for the environmental risk assessment of chemicals: A perspective on environmental regulation in Europe.
    Brown AR; Whale G; Jackson M; Marshall S; Hamer M; Solga A; Kabouw P; Galay-Burgos M; Woods R; Nadzialek S; Maltby L
    Integr Environ Assess Manag; 2017 Jan; 13(1):17-37. PubMed ID: 27243906
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Open Science in regulatory environmental risk assessment.
    Brock TCM; Elliott KC; Gladbach A; Moermond C; Romeis J; Seiler TB; Solomon K; Peter Dohmen G
    Integr Environ Assess Manag; 2021 Nov; 17(6):1229-1242. PubMed ID: 33913617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Flexing the PECs: Predicting environmental concentrations of veterinary drugs in Canadian agricultural soils.
    Kullik SA; Belknap AM
    Integr Environ Assess Manag; 2017 Mar; 13(2):331-341. PubMed ID: 27463842
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Developing Product Environmental Footprint Category Rules (PEFCR) for shampoos: The basis for comparable life cycle assessment.
    Golsteijn L; Lessard L; Campion JF; Capelli A; D'Enfert V; King H; Kremer J; Krugman M; Orliac H; Furnemont SR; Schuh W; Stalmans M; O'Hanlon NW; Coroama M
    Integr Environ Assess Manag; 2018 Sep; 14(5):649-659. PubMed ID: 29870121
    [TBL] [Abstract][Full Text] [Related]  

  • 19. European regulation model for herbal medicine: The assessment of the EU monograph and the safety and efficacy evaluation in marketing authorization or registration in Member States.
    Qu L; Zou W; Wang Y; Wang M
    Phytomedicine; 2018 Mar; 42():219-225. PubMed ID: 29655689
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Key considerations to inform operational EU-specific protection goals: An example for non-target terrestrial plants.
    Bogen C; Mayer CJ; Davies J; Ducrot V
    Integr Environ Assess Manag; 2021 Sep; 17(5):905-910. PubMed ID: 33788411
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.